“…These moieties are biosynthesized via pathways independent of isoprenoids to further give rise to the so-called isoprenoidhybrid compounds, such as novobiocin (27), clorobiocin (27), brasilicardin A (22), KS505a (31), and lavanducyanin (16). Moreover, several actinomycete strains are known to produce polyketide-isoprenoid hybrid compounds, such as furaquinocin (FQ) (23), naphterpin (38), napyradiomycin (40), and marinone (33), all of which were reported to show biological activities and could act as an antitumor drug, an antioxidative agent, a nonsteroidal estrogen receptor antagonist, and an anticancer drug, respectively. Considering that the structures of polyketide moieties, which are derived from 1,3,6,8-tetrahydroxynaphthalene (THN), are almost the same in these compounds, the prenyl moieties are suggested to play important roles in exhibiting diversity in the biological activities of these compounds.…”